User:Mr. Ibrahem/Nadroparin

Nadroparin, sold under the brand name Fraxiparin among others, is a medication used to prevent and treat blood clots, including deep vein thrombosis (DVT) and pulmonary embolism. It may be used following surgery, in people in hospital who are not moving, and as with hemodialysis. It is given by injection under the skin.

Common side effects include bruising at the site of injection and bleeding. Other side effects may include heparin induced thrombocytopenia and high potassium. In those with kidney problems, lower doses may be required. It is a low molecular weight heparin (LMWH) which works by attaching to plasma protein anti-thrombin III. It is made from unfractionated heparin.

Nadroparin was approved for medical use in Australia in 1995. It is on the World Health Organization's List of Essential Medicines as an alternative to enoxaparin. It is available in a number of European countries and Canada but not the United States.